PetCaseFinder

Peer-reviewed veterinary case report

Higher filaggrin enzyme activity found in dogs with atopic skin

By Fanton, Natalia et al.·Published in Veterinary Dermatology·2017·Clinica Veterinaria San Siro via Lampugnano 99 Milano 20151 Italy, Italy·View original on Crossref

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Increased filaggrin‐metabolizing enzyme activity in atopic skin: a pilot study using a canine model of atopic dermatitis

Species:
dog

Plain-English summary

A group of beagles with skin allergies (atopic dermatitis) showed higher levels of certain enzymes in their skin compared to healthy beagles. These enzymes are important for maintaining healthy skin and hydration. The study found that the allergic dogs had more of these enzymes even before they were exposed to allergens, suggesting that their skin barrier might not work properly. This could explain why some dogs develop skin problems when they are exposed to allergens. Further research is needed to understand how this affects treatment options for dogs with skin allergies.

People also search for: dog skin allergies treatment · beagle skin problems · atopic dermatitis in dogs

Abstract

BackgroundFilaggrin (FLG) and its metabolites are essential for skin barrier function and hydration of the stratum corneum. Alteration of the FLG metabolism could be the basis for an abnormal skin barrier in allergic dogs.ObjectivesTo investigate the expression and distribution of calpain‐1, caspase‐14, furin and matriptase, four enzymes involved in FLG metabolism, in the skin of atopic and healthy beagles.MethodsSkin biopsies were collected from four healthy and four atopic beagles before and after allergen exposure. The dogs were challenged for three consecutive days to mimic an acute exposure, or once weekly to mimic a chronic exposure to allergens. Skin biopsies were taken on days 0 (nonlesional), 3 and 10 in the “acute” model and on days 0 (nonlesional), 14 and 28 in the “chronic” model. Four healthy dogs were used as controls. Indirect immunofluorescence was used to analyse the distribution and the expression of FLG enzymes in a semi‐quantitative manner. Five consecutive pictures/section were taken and the intensity analysed tracing the epidermis and using ImageJ on the traced areas. The enzymes’ expression was compared between healthy and atopic nonlesional skin (Day 0) and over time in each group.ResultsAll enzymes were expressed in all layers of the epidermis. A significantly higher expression of calpain‐1 (P = 0.028), caspase 14 (P = 0.028) and matriptase (P = 0.028) was evident in atopic compared to control dogs on Day 0. No differences over time were seen for any enzyme analysed.Conclusions and clinical importanceThis preliminary study suggests an abnormal catabolism of FLG in canine atopic skin.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on Crossref: https://doi.org/10.1111/vde.12443